Overlapping trisomies for human chromosome 21 orthologs produce similar effects on skull and brain morphology of Dp(16)1Yey and Ts65Dn mice
Open accessAbstract
Trisomy 21 results in gene‐dosage imbalance during embryogenesis and throughout life, ultimately causing multiple anomalies that contribute to the clinical manifestations of Down syndrome. Down syndrome is associated with manifestations of variable severity (e.g., heart anomalies, reduced growth, dental anomalies, shortened life‐span). Craniofacial dysmorphology and cognitive dysfunction are consistently observed in all people with Down syndrome. Mouse models are useful for studying the effects of gene‐dosage imbalance on development. We investigated quantitative changes in the skull and brain of the Dp(16)1Yey Down syndrome mouse model and compared these mice to Ts65Dn and Ts1Cje mouse models. Three‐dimensional micro‐computed tomography images of Dp(16)1Yey and euploid mouse crania were morphometrically evaluated. Cerebellar cross‐sectional area, Purkinje cell linear density, and granule cell density were evaluated relative to euploid littermates. Skulls of Dp(16)1Yey and Ts65Dn mice displayed similar changes in craniofacial morphology relative to their respective euploid littermates. Trisomy‐based differences in brain morphology were also similar in Dp(16)1Yey and Ts65Dn mice. These results validate examination of the genetic basis for craniofacial and brain phenotypes in Dp(16)1Yey mice and suggest that they, like Ts65Dn mice, are valuable tools for modeling the effects of trisomy 21 on development. © 2014 Wiley Periodicals, Inc.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Dp16 mice exhibit hyperactive IFN signaling and recapitulate many phenotypes of DS including developmental delays, cranial malformations, and cognitive deficits.
“Notably, Dp16 mice exhibit hyperactive IFN signaling and recapitulate many phenotypes of DS including developmental delays, cranial malformations, and cognitive deficits.38,40,42,43,44,45”
From Interferon signaling modulates Down syndrome-associated Alzheimer’s disease pathology in a mouse model (2025) · cites this paper as [43]
The Discussion (page not provided) reports Down syndrome-like craniofacial abnormalities and cerebellar differences in Dp(16)1Yey mice. Our copy does not report hyperactive IFN signaling, developmental delays, or cognitive deficits in these mice; its mention of behavioral effects in the Introduction concerns Ts65Dn mice. (LLM, conf=0.90)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Sago, H., Carlson, E. J., Smith, D. J., Kilbridge, J., Rubin, E. M., Mobley, W. C., Epstein, C. J., & Huang, T.-T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6256 · Cited by 382 · see citing works
Age and gender effects on microglia and astrocyte numbers in brains of mice
Mouton, P. R., Long, J. M., Lei, D.-L., Howard, V., Jucker, M., Calhoun, M. E., & Ingram, D. K. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03475-3 · Cited by 320 · see citing works
Flagged first, then by citations
Research works printed but not linked: 37
- Allanson JE O’Hara P Farkas LG Nair RC Anthropometric craniofacial pattern profiles in Down syndrome Am J Med Genet 1993 47 748 752 8267006
- Aylward EH Habbak R Warren AC Pulsifer MB Barta PE Jerram M Pearlson GD Cerebellar volume in adults with Down syndrome Arch Neurol 1997a 54 209 212 9041863
- Aylward EH Li Q Habbak QR Warren A Pulsifer MB Barta PE Jerram M Pearlson G Basal ganglia volume in adults with Down syndrome Psychiatry Res 1997b 74 73 82 9204510
- Baxter LL Moran TH Richtsmeier JT Troncoso J Reeves RH Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse Hum Mol Genet 2000 9 195 202 10607830
- Blazek JD Gaddy A Meyer R Roper RJ Li J Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice Bone 2011 48 275 280 20870049 PMC3021595
- Crispino JD GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia Pediatr Blood Cancer 2005 44 40 44 15390312
- Das I Reeves RH The use of mouse models to understand and improve cognitive deficits in Down syndrome Dis Model Mech 2011 4 596 606 21816951 PMC3180223
- Davisson MT Schmidt C Reeves RH Irving NG Akeson EC Harris BS Bronson RT Segmental trisomy as a mouse model for Down syndrome Prog Clin Biol Res 1993 384 117 133 8115398
- Davisson M Akeson E Schmidt C Harris B Farley J Handel MA Impact of trisomy on fertility and meiosis in male mice Hum Reprod 2007 22 468 476 17050550
- Duchon A Raveau M Chevalier C Nalesso V Sharp AJ Herault Y Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: Relevance for modeling down syndrome Mamm Genome 2011 22 674 684 21953411 PMC3224224
- Epstein CJ Cox DR Epstein LB Mouse trisomy 16: An animal model of human trisomy 21 (Down syndrome) Ann N Y Acad Sci 1985 450 157 168 3160287
- Fink GB Madaus WK Walker GF A quantative study of the face in Down’s syndrome Am J Orthod 1975 67 540 553 123708
- Frostad WA Cleall JF Melosky LC Craniofacial complex in the trisomy 21 syndrome (Down’s syndrome) Archs Oral Biol 1971 16 707 722 4254102
- Gardiner KJ Molecular basis of pharmacotherapies for cognition in Down syndrome Trends Pharmacol Sci 2010 31 66 73 19963286 PMC2815198
- Gardiner K Fortna A Bechtel L Davisson MT Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions Gene 2003 318 137 147 14585506
- Gardiner K Herault Y Lott IT Antonarakis SE Reeves RH Dierssen M Down syndrome: From understanding the neurobiology to therapy J Neurosci 2010 30 14943 14945 21068296 PMC3842485
- Guihard-Costa AM Khung S Delbecque K Menez F Delezoide AL Biometry of face and brain in fetuses with trisomy 21 Pediatr Res 2006 59 33 38 16326987
- Hill CA Reeves RH Richtsmeier JT Effects of aneuploidy on skull growth in a mouse model of Down syndrome J Anat 2007 210 394 405 17428201 PMC2100298
- Lele S Richtsmeier JT Euclidean distance matrix analysis: a coordinate-free approach for comparing biological shapes using landmark data Am J Phys Anthropol 1991 86 415 427 1746646
- Li Z Yu T Morishima M Pao A LaDuca J Conroy J Nowak N Matsui S Shiraishi I Yu YE Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities Hum Mol Genet 2007 16 1359 1366 17412756
- Moore CS Hawkins C Franca A Lawler A Devenney B Das I Reeves RH Increased male reproductive success in Ts65Dn “Down syndrome” mice Mamm Genome 2010 21 543 549 21110029 PMC3002156
- Olson LE Roper RJ Baxter LL Carlson EJ Epstein CJ Reeves RH Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/ Ts65Dn exhibit variable severity of cerebellar phenotypes Dev Dyn 2004 230 581 589 15188443
- O’Riordan MW Walker GF Dimensional and proportional characteristics of the face in Down’s syndrome J Dent Handicap 1979 4 6 9 158041
- Parsons T Ryan TM Reeves RH Richtsmeier JT Microstructure of trabecular bone in a mouse model for Down syndrome Anat Rec (Hoboken) 2007 290 414 421 17514765
- Pennington BF Moon J Edgin J Stedron J Nadel L The neuropsychology of Down syndrome: Evidence for hippocampal dysfunction Child Dev 2003 74 75 93 12625437
- Reeves RH Irving NG Moran TH Wohn A Kitt C Sisodia SS Schmidt C Bronson RT Davisson MT A mouse model for Down syndrome exhibits learning and behaviour deficits Nat Genet 1995 11 177 184 7550346
- Reinholdt LG Ding Y Gilbert GJ Czechanski A Solzak JP Roper RJ Johnson MT Donahue LR Lutz C Davisson MT Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn Mamm Genome 2011 22 685 691 21953412 PMC3505986
- Richtsmeier JT Cole TM III Valeri CJ Krovitz G Lele S Preoperative morphology and development in sagittal synostosis J Craniofac Genet Dev Biol 1998 18 64 78 9672839
- Richtsmeier JT Baxter LL Reeves RH Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice Dev Dyn 2000 217 137 145 10706138
- Richtsmeier JT Zumwalt A Carlson EJ Epstein CJ Reeves RH Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome Am J Med Genet 2002 107 317 324 11840489
- Richtsmeier JT Aldridge K DeLeon VB Panchal J Kane AA Marsh JL Yan P Cole TM III Phenotypic integration of neurocranium and brain J Exp Zool B Mol Dev Evol 2006 306B 360 378 16526048 PMC2752667
- Rueda N Florez J Martinez-Cue C Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities Neural Plast Epub 2012 PMID: 22685678 PMC3364589 22685678
- Schmidt-Sidor B Wisniewski KE Shepard TH Sersen EA Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months Clin Neuropathol 1990 9 181 190 2146054
- Shapiro B Amplified developmental instability in Down’s syndrome Ann Hum Genet, London 1975 38 429 437 127546
- Shapiro B Down syndrome—A disruption of homeostasis Am J Med Genet 1983 14 241 269 6220605
- Shapiro BL Gorlin RJ Redman RS Bruhl HH The palate and Down’s syndrome N Engl J Med 1967 276 1460 1463 4226066
- Wiseman FK Alford KA Tybulewicz VL Fisher EM Down syndrome-recent progress and future prospects Hum Mol Genet 2009 18 75 83 19297404 PMC2657943
Cited by
Sorted by citations
Kazuki, Y., Gao, F. J., Li, Y., Moyer, A. J., Devenney, B., Hiramatsu, K., Miyagawa-Tomita, S., Abe, S., Kazuki, K., Kajitani, N., et al. (2020) · eLife · doi:10.7554/elife.56223 · Cited by 125 · see citing works
Self-citationAziz, N. M., Guedj, F., Pennings, J. L. A., Olmos-Serrano, J. L., Siegel, A., Haydar, T. F., & Bianchi, D. W. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031013 · Cited by 118 · see citing works
Waugh, K. A., Minter, R., Baxter, J., Chi, C., Galbraith, M. D., Tuttle, K. D., Eduthan, N. P., Kinning, K. T., Andrysik, Z., Araya, P., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01399-7 · Cited by 117 · see citing works
Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of down Syndrome.
Goodliffe, J. W., Olmos-Serrano, J. L., Aziz, N. M., Pennings, J. L. A., Guedj, F., Bianchi, D. W., & Haydar, T. F. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2513-15.2016 · Cited by 65 · see citing works
Ts66Yah, a mouse model of down syndrome with improved construct and face validity
Duchon, A., del Mar Muñiz Moreno, M., Chevalier, C., Nalesso, V., Andre, P., Fructuoso-Castellar, M., Mondino, M., Po, C., Noblet, V., Birling, M.-C., et al. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049721 · Cited by 58 · see citing works
Analysis of motor dysfunction in down Syndrome reveals motor neuron degeneration.
Watson-Scales, S., Kalmar, B., Lana-Elola, E., Gibbins, D., La Russa, F., Wiseman, F., Williamson, M., Saccon, R., Slender, A., Olerinyova, A., et al. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007383 · Cited by 45 · see citing works
Araya, P., Niemeyer, B., Schade, K., Dunn, L. N., Waugh, K., Busquet, N., Brindley, C., Brown, C., Winkler, C., Lyford, H. R., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113130 · Cited by 7 · see citing works
- Authors
- Starbuck, J. M., Dutka, T., Ratliff, T. S., Reeves, R. H., & Richtsmeier, J. T.
- Affiliations
- Pennsylvania State University (US)
- Johns Hopkins University (US)
- Corresponding author
- Richtsmeier, Joan T.
- Venue
- American Journal of Medical Genetics Part A
- Publisher
- Wiley
- Published
- 2014-05
- Volume
- 164
- Issue
- 8
- Pages
- 1981-1990
- ISSN
- 1552-4825 (ISSN-L)
- 1552-4833
- PMC
- PMC4107150
- OpenAlex
- W2094062112
- Cited by
- 50
- References
- 2
- Citations by year
- 2025: 4 · 2024: 5 · 2023: 6 · 2022: 4 · 2021: 3 · 2020: 6 · 2019: 2 · 2018: 5 · 2017: 4 · 2016: 5 · 2015: 2 · 2014: 3
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Medical Genetics Part A (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Dental and Craniofacial Research (R01-HD038384, R01-DE022988)
- National Institute of Health and Medical Research (R01-DE018500)
- National Science Foundation (DGE-053135, BCS-1061563, BCS-0725227)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Craniofacial Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- Down syndrome, Ts65Dn mouse model, craniofacial dysmorphism, skull morphology, brain structure, cerebellum, Purkinje cells, granule cells, gene dosage imbalance, mouse models of Down syndrome
- MeSH terms
- Animals, Brain, Cerebellum, Disease Models, Animal, Down Syndrome, Humans, Phenotype, Skull, Craniofacial Abnormalities, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review